Published in Am J Epidemiol on December 01, 1977
Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: II. Black men. Am J Public Health (1996) 2.45
Socioeconomic differentials in mortality: evidence from Glasgow graveyards. BMJ (1993) 1.76
Disparities in health status and substance use: ethnicity and socioeconomic factors. Public Health Rep (2002) 1.18
Epidemics in Renaissance Florence. Am J Public Health (1985) 0.78
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol (1999) 4.12
An occupation and exposure linkage system for the study of occupational carcinogenesis. J Occup Med (1980) 2.84
Basic issues in population screening for cancer. J Natl Cancer Inst (1980) 2.62
Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol (1989) 1.73
Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project. J Natl Cancer Inst (1988) 1.71
Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol (1984) 1.62
Risk factors for cancer of the testis. N Engl J Med (1980) 1.57
Epidemiology of bladder cancer. Hematol Oncol Clin North Am (1992) 1.50
Cryptorchidism, hernia, and cancer of the testis. J Natl Cancer Inst (1976) 1.41
Mammographic features of the breast and breast cancer risk. Am J Epidemiol (1982) 1.41
Case definition in case-control studies of the efficacy of screening. Am J Epidemiol (1982) 1.34
Artificial sweeteners and cancer of the lower urinary tract. N Engl J Med (1980) 1.24
Some social and medical characteristics of Army men with testicular cancer. Am J Epidemiol (1976) 1.11
The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol (1982) 1.08
The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol (1982) 1.07
An international study of smoking and bladder cancer. J Urol (1984) 1.06
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. Eur J Cancer (2011) 1.04
A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res (1986) 1.02
Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer (1988) 1.00
Survival of breast cancer patients related to incidence risk factors. Int J Cancer (1972) 0.98
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol (2005) 0.98
Sequential pathogenic components of rates. Am J Epidemiol (1979) 0.97
Some international differences in treatment and survival in breast cancer. Int J Cancer (1976) 0.93
Histologic characteristics of breast cancer in Boston and Tokyo. Int J Cancer (1973) 0.91
Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr (1985) 0.91
Occupation and bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. J Epidemiol Community Health (1985) 0.90
Some international differences in histology and survival in breast cancer. Int J Cancer (1973) 0.89
Oral contraceptives and hepatitis. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 0.88
Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia. J Clin Oncol (1987) 0.88
Artificial sweeteners and bladder cancer in Manchester, U.K., and Nagoya, Japan. Br J Cancer (1982) 0.87
Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women. J Natl Cancer Inst (1986) 0.86
Identifying donor concerns to increase live organ donation. J Transpl Coord (1998) 0.86
Advances in the etiology of urothelial cancer. Urol Clin North Am (1984) 0.86
Case-control study of hepatocellular carcinoma, occupation, and chemical exposures. J Occup Med (1987) 0.86
Bilateral endogenous Escherichia coli endophthalmitis. Arch Intern Med (1980) 0.85
Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst (1986) 0.85
The relation of surgery for prostatic hypertrophy to carcinoma of the prostate. Am J Epidemiol (1993) 0.83
Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study. Cancer Treat Rep (1981) 0.83
Histologic features of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. Int J Cancer (1982) 0.81
Incidence risk factors survival in breast cancer: report on five years of follow-up observation. Eur J Cancer (1977) 0.81
Histologic specificity of the effect of age at birth of first child on breast cancer risk. Int J Cancer (1976) 0.80
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741. J Clin Oncol (1999) 0.80
Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst (1982) 0.79
Relationship of polyps to cancer of the large intestine. J Natl Cancer Inst (1992) 0.79
Epidemics in Renaissance Florence. Am J Public Health (1985) 0.78
Epidemiology and environmental factors in urologic cancer. Cancer (1987) 0.78
Prostatic hypertrophy in greater Boston. J Chronic Dis (1978) 0.77
Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. J Clin Oncol (1990) 0.77
Epidemiology of bladder cancer. Urol Clin North Am (1976) 0.75
Adrenal response to serial cosyntropin stimulation after repeated high-dose prednisone administration in patients with lymphoma. Cancer Treat Rep (1981) 0.75
In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase. Exp Hematol (1983) 0.75
Histologic and mammographic specificity of risk factors for benign breast disease. Cancer (1989) 0.75
In-vitro differentiation of myeloblasts from a patient with acute myeloid leukemia. Am J Clin Pathol (1981) 0.75
Study of abnormal laboratory findings in workers exposed to diazo developer chemicals. J Occup Med (1975) 0.75
Beta-blocker therapy: identification and management of side effects. Heart Lung (1991) 0.75
Phase I-II diaziquone chemotherapy in brain tumors. Cancer Treat Rep (1984) 0.75
Medical evacuations for selected chronic diseases: USARPAC, 1970-71. Mil Med (1974) 0.75
Use of artificial sweeteners by cancer patients. J Natl Cancer Inst (1979) 0.75
T-cell depletion of bone marrow does not inhibit in vitro hematopoiesis. Blut (1985) 0.75
Emergency medical care. Br Med J (1976) 0.75
In vitro drug sensitivity studies of colony-forming units in culture in chronic myelocytic leukemia: lack of specificity between chronic-phase patients and normal donors. Cancer Res (1983) 0.75
Differences between labeling index and DNA histograms in assessing S-phase cells from a homogeneous group of chronic phase CML patients. Cytometry (1985) 0.75
Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemia. Am J Hematol (1985) 0.75
Is self-examination effective in screening for breast cancer? J Natl Cancer Inst (1991) 0.75
Public health value of using epidemiologic information to identify high-risk groups for bladder cancer screening. Semin Oncol (1979) 0.75
Geographic and time trends of coffee imports and bladder cancer. Eur J Cancer (1978) 0.75
Treatment of myeloid blastic crisis of chronic myelogenous leukemia. Cancer Treat Rep (1984) 0.75
Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma. Lung Cancer (2001) 0.75
Lung cancer in young women. Arch Intern Med (1979) 0.75
Urinary tryptophan metabolites and cancer of the bladder in humans. J Natl Cancer Inst (1981) 0.75